BLRX ▼ -10.0% - BioLineRx Ltd. $BLRX BLRX - BioLineRx and Hemispherian Present Phase 1/2a Clinical Study and Pre-Clinical Updates, Including Brain PK/PD Data, at SNO 2026 16-NOV-2026 07:00 AM ET